BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31502411)

  • 1. Subependymal giant cell astrocytoma harboring a PRRC2B-ALK fusion: A case report.
    Tsurubuchi T; Nakano Y; Hirato J; Yoshida A; Muroi A; Sakamoto N; Alexander Z; Matsuda M; Ishikawa E; Kohno T; Yoshioka T; Honda-Kitahara M; Ichimura K; Yamamoto T; Matsumura A
    Pediatr Blood Cancer; 2019 Dec; 66(12):e27995. PubMed ID: 31502411
    [No Abstract]   [Full Text] [Related]  

  • 2. SRBD1-ALK, a Novel ALK Fusion Gene Identified in an Adenocarcinoma Patient by Next-Generation Sequencing.
    Hou X; Xu H; Chen L
    J Thorac Oncol; 2019 Apr; 14(4):e72-e73. PubMed ID: 30922581
    [No Abstract]   [Full Text] [Related]  

  • 3. Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma.
    Lucas CG; Abdullaev Z; Bruggers CS; Mirchia K; Whipple NS; Alashari MM; Lowichik A; Cheshier S; Phillips JJ; Devine P; Solomon DA; Quezado M; Aldape KD; Perry A
    Acta Neuropathol; 2022 Feb; 143(2):283-286. PubMed ID: 34910220
    [No Abstract]   [Full Text] [Related]  

  • 4. ALK-positive histiocytosis with
    Gupta GK; Xi L; Pack SD; Jones JB; Pittaluga S; Raffeld M; Jaffe ES
    Haematologica; 2019 Nov; 104(11):e534-e536. PubMed ID: 31371408
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of a novel GORASP2-ALK fusion in an ALK-positive large B-cell lymphoma.
    Ise M; Kageyama H; Araki A; Itami M
    Leuk Lymphoma; 2019 Feb; 60(2):493-497. PubMed ID: 30187817
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel KIF5B-ALK fusion in a child with an atypical central nervous system inflammatory myofibroblastic tumour.
    Maruggi M; Malicki DM; Levy ML; Crawford JR
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30344149
    [No Abstract]   [Full Text] [Related]  

  • 7. A Rare Fusion of CLIP1 and ALK in a Case of Non-Small-Cell Lung Cancer With Neuroendocrine Features.
    Pinsolle J; Mondet J; Duruisseaux M; d'Alnoncourt S; Magnat N; de Fraipont F; Moro-Sibilot D; Toffart AC; Brambilla E; McLeer-Florin A
    Clin Lung Cancer; 2019 Sep; 20(5):e535-e540. PubMed ID: 31171381
    [No Abstract]   [Full Text] [Related]  

  • 8. RAF gene fusions are specific to pilocytic astrocytoma in a broad paediatric brain tumour cohort.
    Lawson AR; Tatevossian RG; Phipps KP; Picker SR; Michalski A; Sheer D; Jacques TS; Forshew T
    Acta Neuropathol; 2010 Aug; 120(2):271-3. PubMed ID: 20454969
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches.
    Vendrell JA; Taviaux S; Béganton B; Godreuil S; Audran P; Grand D; Clermont E; Serre I; Szablewski V; Coopman P; Mazières J; Costes V; Pujol JL; Brousset P; Rouquette I; Solassol J
    Sci Rep; 2017 Oct; 7(1):12510. PubMed ID: 28970558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of ALK Immunohistochemistry for Optimal Therapeutic Strategy of Pulmonary Large-cell Neuroendocrine Carcinoma and Identification of a Novel
    Shimizu N; Akashi Y; Fujii T; Shiono H; Yane K; Kitahara T; Ohta Y; Kakudo K; Wakasa T
    Anticancer Res; 2019 Jan; 39(1):413-420. PubMed ID: 30591488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report.
    Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y
    J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation Sequencing Identified a Novel WDPCP-ALK Fusion Sensitive to Crizotinib in Lung Adenocarcinoma.
    He Z; Wu X; Ma S; Zhang C; Zhang Z; Wang S; Yu S; Wang Q
    Clin Lung Cancer; 2019 Sep; 20(5):e548-e551. PubMed ID: 31281052
    [No Abstract]   [Full Text] [Related]  

  • 13. RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance.
    Vollbrecht C; Lenze D; Hummel M; Lehmann A; Moebs M; Frost N; Jurmeister P; Schweizer L; Kellner U; Dietel M; von Laffert M
    BMC Cancer; 2018 Nov; 18(1):1158. PubMed ID: 30466405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CUX1-ALK, a Novel ALK Rearrangement That Responds to Crizotinib in Non-Small Cell Lung Cancer.
    Zhang M; Wang Q; Ding Y; Wang G; Chu Y; He X; Wu X; Shao YW; Lu K
    J Thorac Oncol; 2018 Nov; 13(11):1792-1797. PubMed ID: 30010043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report: Temporal Heterogeneity of ALK Activating Mutations in Sequential ALK TKI-Treated Non-Small-Cell Lung Cancer Revealed Using NGS-Based Liquid Biopsy.
    Ding M; Deng L; Yu R; Lu D; Bai Y; Wu X; Shao YW; Yang Y
    Clin Lung Cancer; 2019 May; 20(3):e229-e232. PubMed ID: 30948231
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion.
    Furugaki K; Mochizuki M; Kohno M; Shu S; Harada N; Yoshimura Y
    BMC Cancer; 2019 Apr; 19(1):301. PubMed ID: 30943926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and Characterization of Recurrent, Targetable ALK Fusions in Leiomyosarcoma.
    Davis LE; Nusser KD; Przybyl J; Pittsenbarger J; Hofmann NE; Varma S; Vennam S; Debiec-Rychter M; van de Rijn M; Davare MA
    Mol Cancer Res; 2019 Mar; 17(3):676-685. PubMed ID: 30518629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated ALK-positive histiocytosis with
    Qiu L; Weitzman SP; Nastoupil LJ; Williams MD; Medeiros LJ; Vega F
    Leuk Lymphoma; 2021 May; 62(5):1234-1238. PubMed ID: 33353436
    [No Abstract]   [Full Text] [Related]  

  • 19. Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib.
    Graetz D; Crews KR; Azzato EM; Singh RK; Raimondi S; Mason J; Valentine M; Mullighan CG; Holland A; Inaba H; Leventaki V
    Haematologica; 2019 May; 104(5):e218-e221. PubMed ID: 30819904
    [No Abstract]   [Full Text] [Related]  

  • 20. Notable therapeutic response in a patient with systemic juvenile xanthogranuloma with KIF5B-ALK fusion.
    Sugiyama M; Hirabayashi S; Ishi Y; Kikuchi J; Ishikura A; Motegi H; Ueda Y; Sawai S; Hara K; Terashita Y; Cho Y; Takakuwa E; Honda S; Yamaguchi S; Kinoshita I; Manabe A
    Pediatr Blood Cancer; 2021 Nov; 68(11):e29227. PubMed ID: 34245207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.